QV Bioelectronics raises £4.5m in funding led by PXN Ventures to treat brain cancer with implantable device

QV Bioelectronics develops an implantable medical device that delivers therapeutic electric fields to residual brain cancer cells, aiming to reduce tumour regrowth following surgery for patients with glioblastoma.